Pick up any cosmetic product and find the expiration date. That date tells you when the product becomes unsafe — when microbial growth or preservative failure reaches a regulatory threshold. It tells you nothing about potency. The active ingredients inside have been degrading since the day the batch was sealed. And by the time you open it, that degradation has likely been running for well over a year.
The industry supply chain follows a predictable sequence: manufacture, warehouse storage, distribution to regional hubs, shipment to retailers, stocking on shelves, and finally — perhaps 18 to 24 months later — purchase by a customer. Each stage adds time. Each stage exposes the product to temperature conditions that accelerate degradation. The expiration date on the bottom of the bottle is a safety metric. It has nothing to do with whether the actives still work.
The Thermal Reality of Warehouses
Warehouses are not climate-controlled laboratories. In summer, internal temperatures in distribution centres routinely exceed 35°C — especially in the upper racks where lighter inventory is stored. In winter, unheated sections drop near freezing. A product sitting in a warehouse for six to twelve months experiences thermal cycling that laboratory stability studies rarely model. The label says "store in a cool, dry place." The warehouse delivers neither.
The Arrhenius equation describes this precisely: for every 10°C increase in temperature, the rate of chemical degradation roughly doubles. A peptide that would retain 90% potency after 12 months at 20°C may retain less than 50% after the same period at 30°C. The math is consistent across multiple active classes. Temperature drives reaction rates. Warehouses are hot. The conclusion is not ambiguous.
What Made-to-Order Changes
At NeolabCare, the supply chain is inverted. Production begins when you place your reservation — not eighteen months before. Your formula is compounded, tested, and dispatched within seven days. The pre-use timeline collapses from 18-24 months to one week. Degradation during this window is negligible. Every active arrives at or near its peak concentration.
This is not a marketing claim. It is a measurable specification. We test potency on every batch at the time of compounding and again at the time of dispatch. The difference is documented. When we say a bottle contains a clinical concentration of GHK-Cu, we mean it contains that concentration when you open it — not when it left a factory floor in a different calendar year.
The warehouse problem is invisible to consumers because no brand has an incentive to make it visible. The longer a product can sit on a shelf, the cheaper the supply chain. Made-to-order is expensive. It requires production agility, short-run quality control, and a logistics system that treats every order as a fresh batch. But if the alternative is selling degraded actives at full price, the choice is not difficult. It is obvious.